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One of the mitogen-activated protein kinases, p38α plays a crucial role in various
inflammatory diseases and apoptosis of various types of cells. In this study, we
investigated the pathophysiological roles of p38α in spinal cord injury (SCI), using a
mouse model. Lateral hemisection at T9 of the SC was performed in wild type (WT) and
p38α+/− mice (p38α−/− showed embryonic lethality). p38α+/− mice showed a better
functional recovery from SCI-associated paralyzed hindlimbs compared to WT mice at
7 days post-injury (dpi), which remained until 28 dpi (an end time point of monitoring the
behavior). In histopathological analysis at 28 dpi, there was more axonal regeneration
with remyelination on the caudal side of the lesion epicenter in p38α+/− mice than in
WT mice. At 7 dpi, infiltration of inflammatory cells into the lesion and expression of
cytokines in the lesion were reduced in p38α+/− mice compared with WT mice. At the
same time point, the number of apoptotic oligodendrocytes in the white matter at the
caudal boarder of the lesion of p38α+/− mice was lower than that of WT mice. At 14 dpi,
more neural and oligodendrocyte precursor cells in the gray matter and white matter,
respectively, were observed around the lesion epicenter of p38α+/− mice compared
with the case of WT mice. At the same time point, astrocytic scar formation was less
apparent in p38α+/− than in WT mice, while compaction of inflammatory immune cells
associated with the wound contraction was more apparent in p38α+/− than in WT mice.
Furthermore, we verified the effectiveness of oral administration of SB239063, a p38α
inhibitor on the hindlimb locomotor recovery after SCI. These results suggest that p38α
deeply contributes to the pathogenesis of SCI and that inhibition of p38α is a beneficial
strategy to recovery from SCI.
Keywords: p38 mitogen-activated protein kinases, spinal cord injury (SCI), recovery of locomotor activity, tissue
degeneration, tissue regeneration
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INTRODUCTION
Spinal cord injury (SCI) results in limited motor function
recovery under the chronic phase, mainly because of the poor
regenerative capability of adult mammalian central nervous
system (CNS) (Horner and Gage, 2000). SCI is composed of
three phases, acute, secondary and chronic, and its outcomes
are influenced by the secondary phase (Oyinbo, 2011). The
secondary phase is characterized by inflammation-triggered
events as follows: edema, apoptosis of cells including neurons
and oligodendrocytes, demyelination, astrocytic scar formation
and so on (Zhou et al., 2014). Under the secondary phase of
SCI, gradual functional recovery is observed in several animals
including humans, the extent of which is inversely related to
the intensity of primary damage (Becker et al., 2003). It is thus
logical to postulate that reduction of secondary damage waves
by controlling inflammation-triggered events may improve the
functional recovery after SCI.
p38 is one of mitogen-activated protein kinases (MAPKs)
which transduces a variety of extracellular signals to the
transcriptional machinery. By using genetically engineered mice,
it has been demonstrated that p38 participates at least in
inflammatory responses and cell fate decision including apoptosis
(O’Keefe et al., 2007; Ventura et al., 2007; Kang et al., 2008;
Risco et al., 2012). Among four mammalian isoforms of p38
(α, β, γ, and δ), p38α is expressed ubiquitously in adult tissues
and functions as a central player of p38 isoforms (Kumar
et al., 2003). Although p38α gene (MAPK14) deficiency results
in lethality in homozygous embryonic mice, the p38α+/−
mouse is a useful tool for studying the in vivo role of p38α
in certain disease models (Tamura et al., 2000; Takanami-
Ohnishi et al., 2002; Matsuo et al., 2006). In particular, p38α+/−
mice show an outstanding resistance to neurodegenerative
diseases such as epileptic seizure and experimental autoimmune
encephalomyelitis (EAE, an animal model of multiple sclerosis
associated with demyelination in the SC) (Namiki et al., 2007,
2012). In contrast, the deterioration of EAE was observed in
transgenic mice expressing a constitutive active form of MKK6,
a p38-specific activator (Noubade et al., 2011). Furthermore,
self-renewal activity and neural differentiation capacity of neural
stem cells (NSCs) in the hippocampus of p38α+/− mice are
higher than those of WT mice (Yoshioka et al., 2015). These
previous findings tempt us to think that inhibition of p38αmay be
beneficial to the functional recovery after SCI. In fact, it has been
demonstrated that a p38α inhibitor, SB203580 could reduce the
damage of hindlimb function after SCI (Horiuchi et al., 2003). In
contrast, another group showed that SB203580 failed to improve
functional outcome after SCI (Stirling et al., 2008). Those reports
are fully controversial though employing a similar SCI protocol
and a same administration procedure. Therefore, whether p38α
is recognized as a potential therapeutic target in SCI is still under
debate.
Here, we first showed that the hindlimb locomotor behavior
was improved in p38α+/− mice compared to WT mice. As the
mechanisms underlying the improved signs of SCI in p38α+/−
mice, various pathological aspects under the secondary phase of
SCI were examined between WT and p38α+/− mice. We finally
showed that oral administration of SB239063, a p38α-specific
inhibitor might be beneficial to functional recovery after SCI.
MATERIALS AND METHODS
Animals
All animal procedures conformed to the Japanese regulations
for animal care and use, following guideline for Animal
Experimentation of the Japanese Association for Laboratory
Animal Science, and were approved by the Animal Care and
Use Committee of Chiba University. Male mice heterozygous
for targeted disruption of the p38α gene (Tamura et al., 2000)
were crossed with C57BL6J female mice (Tokyo Experimental
Animal Co., Tokyo, Japan) to generate p38α+/− and p38α+/+
[Wild type (WT)] mice. Genotyping by PCR analysis of tail-
derived DNA was performed according to our previous report
(Takanami-Ohnishi et al., 2002).
SCI Model
Male WT and p38α+/− mice aged 10–14 weeks were used for
each experiment. Mice were deeply anesthetized with isoflurane.
Laminectomy was performed at the thoracic levels of T8-10
to expose the spinal cord (SC), taking care not to damage the
SC. Mice of the sham-operated group underwent laminectomy
alone. Using a micro dissecting forceps, mice of the SCI group
underwent right lateral hemisection at T9. Then, the muscle
layer and the skin were sutured. After awaking fully from
anesthesia, paralysis of the right hindlimb was assessed. The
right hindlimb movement was not observed in this SCI model
mice at the surgical day (day 0). At day 0, therefore, mice
showing the movement of right hindlimb or with paraplegia
were excluded from the following assessment and experiments.
The urine was squeezed out by manual abdominal pressure on
the bladder twice daily until reflex bladder function would be
recovered. To determine the effect of a p38α inhibitor on SCI,
each mouse received oral administration of SB239063 in acidified
0.5% tragacanth (10 mg/kg per day; Sigma–Aldrich, St. Louis,
MO, USA) at 1, 2, and 3 dpi, and the control group received oral
administration of vehicles, acidified 0.5% tragacanth.
Behavior Study
We evaluated the motor function of the SCI-associated paralyzed
hindlimbs from 0 to 28 days post-injury (dpi), based on Basso
Mouse Scale (BMS) (Basso et al., 2006). The BMS is a 9 point scale
for assessment of functional recovery of mice’s hindlimbs. Mice
were forced to walk in an open field, and their right hindlimbs
movement was observed for 4 min to score based on BMS.
Tissue Preparation and Histological
Analysis
Mice were anesthetized lethally and transcardially perfused
with ice-cold phosphate-buffered saline (PBS). SCs including
the lesions were carefully dissected out, fixed overnight in 4%
paraformaldehyde and subsequently immersed in 30% sucrose
for 2 days to cryoprotect the tissues. After embedding into OCT
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compound, the samples were transversely or sagittally sectioned
at a thickness of 20 µm. Sagittal and transverse sections were
stained with hematoxylin-eosin (HE) and by a Kluver-Barrera’s
(KB) method, respectively. The injury-associated leukocyte
infiltration area and Luxol Fast Blue (LFB)-staining area in
sections stained with HE and by a KB method, respectively,
were quantified using Macromax MVC-DU (GOKO, Kanagawa,
Japan).
Tracing Study
For anterograde tracing of axons, a total of 2µl of 10% Texas Red-
conjugated biotinylated dextran amine (Texas Red-BDA; Vector
Laboratories, Burlingame, CA, USA) was injected into four sites
of sensorimotor cortex in the left side (contralateral to the side
of injured SC) at 14 dpi. The scalp was cut and a hole was
carefully drilled into the skull, and then Texas Red-BDA was
injected into the sensorimotor cortex using a 10 µl Hamilton
microsyringe. The scalp was closed with suture. Mice applied
with Texas Red-BDA were killed at 28 dpi. Sagittal sections
(20 µm thick) from the SCs were observed by a fluorescence
microscope (Axio Imager A2, Zeiss, Oberkochen, Germany).
Texas Red-BDA-staining area in a visual field was quantified
using ImageJ 1.45.
Immunofluorescence Study
The freshly cut sagittal sections (20 µm thick) placed on poly-
L-lysine-coated slides were pretreated with 1:10 FcR blocking
agent (Miltenyi Biotec, Gladbach, Germany) for 10 min and
reacted with various primary antibodies as follows: anti-CNPase
(Sigma–Aldrich, St. Louis, MO, USA) to label oligodendrocytes,
anti-cleaved caspase-3 (Cell Signaling Tech., Beverly, MA, USA)
to label apoptotic cells, Cy3-conjugated anti-glial fibrillary acidic
protein (GFAP; Sigma–Aldrich) to label astrocytes, anti-Iba1
(WAKO, Osaka, Japan) to label microglia or macrophages, Cy3-
conjugated anti-NG2 (Merck Millipore, Billerica, MA, USA)
to label to oligodendrocyte precursors, FITC-conjugated anti-
CD45.2 (BioLegend, San Diego, CA, USA) to label leukocytes,
biotin-labeled anti-CD3 (Affymetrix, Santa Clara, CA, USA)
to label T lymphocytes. After staining with each appropriate
fluorescein-conjugated second antibody or streptavidin, 4′,
6-diamidino-2-phenylindole (DAPI) was applied for nuclear
staining before the final washing step. The sections were
observed by a fluorescence microscope. In case of counting
cells immunoreacted with antibodies, 4–5 sections from each
SC were randomly selected. Under 200× magnification, two
fields within 1 mm centered on the lesion epicenter in the SCI
group or the corresponding segment in the sham-operated group
were randomly chosen in each section, and fluorescent signal-
expressing cells were counted and averaged (/0.1 mm2).
Western Blot Array Analysis
Male WT and p38α+/− mice of the sham-operated and SCI
groups were anesthetized and sacrificed at 7 dpi. Then, each
unilateral SC in the right side including with the injured region
was dissected out, and cut with the length of 6 mm from the
edge of the rostral lesion to caudal side. The SC sample was
homogenized, and centrifuged at 9000 × g for 20 min at 4◦C.
The resulting supernatant was subjected to protein assay. Protein
sample (60 µg/mouse) from five mice of each group (WT-sham,
WT-SCI, p38α+/−-sham, p38α+/−-SCI) was mixed (300 µg in
each group) and subjected to RayBio R© Biotin Label-based Mouse
Antibody Array 1 (RayBiotech, Norcross, GA, USA), and changes
in expression levels of 308 inflammation-related proteins in the
samples were evaluated. The array was performed according
to the manufacturer’s instructions. Using a densitometer, each
signal was normalized to the positive internal controls included
in the array membrane and expressed as induction ratio of the
sham-operated value.
Statistical Analysis
All analyses were conducted through GraphPad Prism Version
6 (GraphPad Software, San Diego, CA, USA). Statistical
significance was determined by Mann–Whitney U test, Student’s
t-test or analysis of variance (ANOVA) followed by Tukey’s test,
and P-value of< 0.05 were considered to be significant.
RESULTS AND DISCUSSION
Recovery of Hindlimb Locomotor
Behavior Related to Histopathological
Findings in SC after SCI between
p38α+/− and WT Mice
We first addressed to whether a single copy disruption of
p38α gene might affect functional recovery of hindlimb after
lateral hemisection employed as SCI model in this study.
Although such a laceration injury of SC is not typically seen
clinically, a hemisection model is suitable to investigate the
pathophysiological elements inhibiting or promoting axonal
regeneration across or around the laceration injury as well as the
resulting functional impairment and potential recovery (Onifer
et al., 2007). As shown in Figure 1, p38α+/− mice showed
significantly less severe neurological function of paralyzed SCI-
associated right hindlimbs at 7 dpi, and then the more improved
locomotor function in p38α+/− mice than in WT mice remained
until 28 dpi. Therefore, a single copy disruption of p38α gene
suppressed the functional disturbance in the hemisection model
of SCI.
Then, histopathological changes such as leukocytic
infiltration-associated lesion area, myelinated area and axonal
regeneration between the two genotypes were examined after
SCI (Figure 2). We calculated the leucocytic infiltration area
using sagittal sections stained with HE at 1, 2, and 4 wpi
(Figures 2A,C). There was no significant difference in the
size of leukocyte infiltration-associated lesion between the two
genotypes at 1 wpi. The SCI-induced lesion was reduced in a
time-dependent manner in the two genotypes at 2 and 4 wpi
but significantly smaller in p38α+/− mice than in WT mice
at each time point. These results suggest that the functional
and histopathological recovery after SCI may be enhanced
or accelerated in p38α+/− mice compared with WT mice.
Remyelination of regenerated axons are likely to be one of key
mechanisms involved in the spontaneous recovery of motor
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FIGURE 1 | Time course of hindlimb locomotor behavior after spinal
cord injury (SCI). Wild type (WT) and p38α+/− mice with SCI were observed
daily until 28 dpi, and scored based on BMS. Data are shown as
mean ± SEM (n = 5). The difference between WT (filled squares) and
p38α+/− (open circles) mice was statistically significant (∗P < 0.05) as
determined by Mann–Whitney U test for unpaired values at each time point.
function after SCI (Lu et al., 2012). As shown in Figure 2B, Luxol
Fast Blue (LFB)-stained area on transverse section of the SC of
the two genotypes was significantly smaller in the SCI group
compared with the sham-operated group. And, the LFB-positive
ratio was significantly larger in p38α+/− mice than in WT mice
at 4 wpi (Figure 2C). At 2 wpi, the LFB-positive staining in
the white matter of SC of the two genotypes was much weaker
than the case at 4 wpi (data not shown), suggesting that axonal
remyelination may occur at least over a time period ranging
from 2 to 4 wpi. Likewise, axons labeled by an anterograde tracer,
Texas Red-BDA were more frequently observed in caudal part
of the SC of p38α+/− mice than of WT mice at 4 wpi, a semi-
quantitative analysis of which showed a significant difference
between the both genotypes (Figure 2D). The labeled frequency
in rostral part of the SC was equally high between the two
genotypes because axonal degeneration predominantly occurred
in caudal part of the SC, and axons are intact in 5 mm rostral to
the lesion epicenter of SC after the hemi-section injury. These
results suggest that axonal regeneration and remyelination after
SCI may be enhanced or accelerated in p38α+/− mice compared
with WT mice. To elucidate the mechanism underlying the
improved signs of SCI in p38α+/− mice, we focused on various
pathological events at 1 and 2 wpi in which the difference
in improvement of spontaneous locomotor ability after SCI
between p38α+/− mice and WT mice was recognized and then
manifested.
Characterization of Inflammatory
Response and Evaluation of
Oligodendrocyte Apoptosis between
p38α+/− and WT Mice at 1 wpi
A significant importance of leukocytes-mediated inflammatory
reaction is well known in the development of SCI. In
particular, T lymphocytes invade the lesion site, concomitantly
FIGURE 2 | Histopathological changes after SCI. (A) Typical profiles of
HE-stained sagittal SC sections from WT and p38α+/− mice at 1, 2, and
4 weeks post-injury. (B) Transverse SC sections from WT and p38α+/− mice
at 4 weeks post-injury (1 mm caudal of the lesion epicenter) or with
sham-operation (the corresponding site) were stained by a KB method.
LFB-staining area was surrounded with the dotted lines. (C) Quantitative
evaluation of (A) and (B). Left column, SCI-associated leukocyte infiltration
into SC of WT (open bars) and p38α+/− (closed bars) mice. Right column,
ratio of LFB-staining area to right hemi-SC area in WT (open bars) and
p38α+/− (closed bars) mice. Data are shown as mean ± SEM (n = 5).
∗P < 0.05 (ANOVA followed by Tukey’s test), #P < 0.05 (Student’s t-test for
unpaired values). (D) Representative images of Texas Red-BDA-labeled axons
in the white matter of SC of WT and p38α+/− mice at 4 weeks post-injury. In
the SCI group, sagittal sections of SC at 5 mm rostral and 5 mm caudal to the
lesion epicenter were observed. In the sham-operated group, SC segment
corresponding to the lesion epicenter (T9) of the SCI group was observed.
Texas-Red BDA staining area caudal to the lesion epicenter was expressed as
the percentage of the whole field. Data are shown as mean ± SEM (n = 5).
∗P < 0.05 (Student’s t-test for unpaired values).
to macrophages and secrete cytokines in the lesion epicenter,
which results in axonal damage and motor neuron apoptosis
after SCI (Brunn et al., 2008; Beck et al., 2010). Moreover, a
previous report demonstrated that the expression of p38 was
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enhanced in resident and infiltrating immune cell after SCI
(Stirling et al., 2008). Thus, we elucidated cell populations of
leukocytes and T lymphocytes detected as CD45+ and CD3+,
respectively, in the lesion. As shown in Figures 3A,B, CD45+
and CD3+ cells were observed in the lesion of the two genotypes
at 1 wpi, each number of which was significantly lower in
p38α+/− mice than WT mice. In general, neutrophils are a
major cell population of CD45+ cells and contribute to both
the progression of damage and the tissue repair after SCI
(Neirinckx et al., 2014). However, Ly6G+ neutrophils were hardly
detected in the lesion at 1 wpi (data not shown), which was
supported by a previous report that neutrophil recruitment
showed fast kinetics reaching a peak at 1 day and immediately
declining to the baseline within several days (Donnelly and
Popovich, 2008). Considering cell types of leukocytes in the
inflammation of SCI, thus, CD45+CD3− cells in the lesion at
1 wpi may be mainly monocytes/macrophages. At the same
time point, we also investigated the comprehensive analysis
of SCI-induced change in expression of inflammation-related
proteins in the SC. As shown in Figure 3C, we found 15
molecules [C-X-C motif chemokine 12 (CXCL12); Eotaxin-2;
Galectin-3; insulin-like growth factor 2 (IGF-II), IL-2 receptor
γ (IL-2Rγ); IL-9; IL-9 receptor (IL-9R); IL-12/p70; Kremen-1;
macrophage inflammatory protein 1α (MIP-1α); MIP-2; matrix
metalloproteinase 9 (MMP-9); Osteoactivin; tissue inhibitors
of metalloproteinase 4 (TIMP-4); Toll-like receptor 2 (TLR2)]
showing a clear difference in their expression between WT and
p38α+/− mice. The lower expression of MIP-1α, MIP-2, and
MMP-9 was corroborated as less leucocyte infiltration in the
injured SC of p38α+/− mice (Jaerve and Müller, 2012). In
particular, MMP-9 has been thought to open the blood-SC barrier
and promote migration of leukocytes into the lesion, which
may directly influence the severity of SCI (Noble et al., 2002).
It has been also reported that MMP-9 and CXCL12 function
synergistically to facilitate migration of blood-borne monocyte
(Zhang et al., 2011), although CXCL12 has been regarded as one
of key chemoattractants that regulates migration of homeostatic
stem and progenitor cells in animal models of CNS injury and
promote axonal sprouting (Jaerve and Müller, 2012). Therefore,
it can be speculated that the decreased expression of both
MMP-9 and CXCL12 in p38α+/− mice may lead to the less
infiltrating leucocytes (Stirling et al., 2008). Furthermore, MIP-
1α and CXCL12 can recruit T lymphocytes into the injured site
(Ousman and David, 2001; Jaerve and Müller, 2012). Thus, their
decreased expression may be closely related to the reduction of T
cell infiltration in p38α+/− mice. On the other hand, Galectin-
3 and TLR2 have been reported to have protective effects on
SCI through regulating inflammatory response (Kigerl et al.,
2007; Stirling et al., 2014; Gensel et al., 2015; Mostacada et al.,
2015). Among the 15 molecules, only SCI-induced Galectin-
3 was higher in p38α+/− mice compared with WT mice,
suggesting that the increase of Galectin-3 may also contribute
to the less infiltrating leucocytes in p38α+/− mice. Further
study is needed to elucidate whether functional inhibition of
each molecule by its neutralizing antibody affects the severity
of SCI. However, the decrease in concomitant infiltration of
monocytes/macrophages and T lymphocytes associated with
FIGURE 3 | Inflammatory profiles 1 week after SCI. (A) Typical profile of
CD3+CD45+ cells in the lesion epicenter of the two genotypes at 1 week
post-injury. Asterisks indicate double-positive cells. (B) Quantitative evaluation
of (A). CD3+ cells and CD45+ cells in the injured site within 500 µm
rostrocaudal of the lesion epicenter increased in both WT (open bars) and
p38α+/− (closed bars) mice at 1 week post-injury, the number of which was
significantly lower in p38α+/− mice than WT mice. Data are shown as
mean ± SEM (n = 5). ∗P < 0.05 (ANOVA followed by Tukey’s test).
(C) SCI-induced changes in expression of cytokines in the SC between WT
and p38α+/− mice. Collected SC protein sample from five mice of each
group (WT-sham, WT-SCI, p38α+/−-sham or p38α+/−-SCI) were subjected
to protein array for 308 molecules. Three independent experiments were
conducted (15 mice in each group). Using a densitometer, each signal was
normalized to the positive internal controls included in the array membrane
(P1-a), and expressed as induction ratio of the sham-operated value. Among
61 molecules (≥2, induction ratio in WT group), 15 molecules showed a
significant difference in their induction ratio between the two genotypes. Data
are shown as mean ± SEM (n = 3). The difference between WT (open
squares) and p38α+/− (filled squares) mice was statistically significant
(∗P < 0.05) as determined by Student’s t-test for unpaired values.
the changes in expression of several cytokines/chemokines
may contribute to the less development of SCI in p38α+/−
mice.
In CNS, p38 mainly localizes in myelin sheath but not in axon
(Maruyama et al., 2000). It has been reported that inhibition
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of p38 prevents myelin structure destruction associated with
oligodendrocytic apoptosis and ameliorates neurological deficits
after SCI (Horiuchi et al., 2003). It has also been reported
that apoptosis of oligodendrocyte would occur about 1 week
after SCI and cause demyelination and axonal disturbance
(Li et al., 1999; Dong et al., 2003). As a reliable strategy,
colocalized cells of CNPase and cleaved caspase-3 are regarded
as oligodendrocytes under programmed cell death in human
SCI (Emery et al., 1998). Then, we evaluated a cell population
of cleaved caspase-3+CNPase+ cells in the white matter of the
lesion. As shown in Figure 4, cleaved caspase-3+CNPase+ cells
were typically observed in the SCI group of the two genotypes
at 1 wpi (A), the number of which was significantly lower
in p38α+/− mice than WT mice (B). On the other hand,
Nissle+ neuronal cells decreased in the gray matter of SC around
the lesion epicenter in the two genotypes at 1 wpi, which
was significantly moderate in p38α+/− mice than WT mice
(Supplementary Figure 1). These results indicated that p38α+/−
mice showed resistance to cell death of oligodendrocytes and
neurons at 1 wpi. Hence, the inflammatory responses and
cell death of oligodendrocytes and neurons after SCI were
reduced by a single copy disruption of p38α gene. Next, we
elucidated a role of p38α in the tissue regeneration process
after SCI.
Astrocytic Scar Formation and Increase
in Oligodendrocyte Precursor Cells after
SCI between p38α+/− and WT Mice
In a great numbers of studies, glial scar by reactive astrocytes
has been regarded as physical barriers to successful axon
regeneration (Silver and Miller, 2004). In contrast, recent
studies have provided the possibility that reactive astrogliosis
have beneficial effects in axonal regeneration via forming
the astrocyte bridge, a scaffold for axonal growth (Anderson
et al., 2016; Mokalled et al., 2016). On the other hand,
activated microglias and macrophages markedly infiltrate into
the lesion of CNS injury, the spread degree of which is
closely associated with substantial tissue repair and functional
restoration (Penkowa et al., 1999). Thus, the cellular formation
of GFAP+ astrocytes and Iba1+microglias/macrophages between
p38α+/− mice and WT mice was examined at 2 wpi. As
shown in Figure 5, astrocytic scar formation was observed
in the epicenter of the two genotypes, which was more
massive in WT mice (B and C) than p38α+/− mice (F and
G). Likewise, a larger numbers of reactive astrocytes with
hypertrophied somas and long processes were observed in WT
mice (D) than p38α+/− mice (H). These phenomena were
supported by a previous study that astrogliosis after CNS damage
might be attenuated in astrocyte-specific p38α-knockout mice
(Roy Choudhury et al., 2014). On the other hand, Iba1+
microglias/macrophages were accumulated more compactly
between rostrocaudal GFAP+ reactive astrocytes in p38α+/−
mice than WT mice (Figures 5B,C,F,G). Likewise, the distance
between rostrocaudal glial scars was shorter in p38α+/− mice
than WT mice (Figures 5A,E), indicating that contraction of
lesion area was enhanced in p38α+/− mice compared with WT
FIGURE 4 | Changes in numbers of apoptotic oligodendrocytes in the
white matter 1 week after SCI. (A) Typical profile of cleaved
caspase-3+CNPase+ cells in the white matter at the caudal boarder of the
lesion of the two genotypes at 1 week post-injury. Asterisks indicate
double-positive cells. (B) Cleaved caspase-3+CNPase+ cells in the injured
site within 500 µm rostrocaudal of the lesion epicenter increased in both WT
(open bars) and p38α+/− (closed bars) mice at 1 week post-injury, the
number of which was significantly lower in p38α+/− mice than WT mice. Data
are shown as mean ± SEM (n = 4–5). ∗P < 0.05 (ANOVA followed by Tukey’s
test).
mice. It has been reported that the Stat3-upregulated migratory
activity of reactive astrocytes to seclude inflammatory cells
enhances contraction of lesion area and functional restoration
after SCI (Okada et al., 2006). Moreover, a loss of function of
p38α in astrocyte negatively affects its cellular migration activity
(Roy Choudhury et al., 2014). Thus, more typical compaction
of microglias/macrophages associated with smaller wound area
in p38α+/− mice compared with WT mice is of interest.
Probably, at least the less infiltration of inflammatory cells
related to expression of proinflammatory cytokines (Figure 3)
may positively affect the wound healing process in p38α+/−
mice even though astrogliosis-forming activity is moderate
compared with WT mice. In addition, it was also provided the
possibility that the contribution of NSCs to wound healing/tissue
regeneration process after SCI might be potentiated in p38α+/−
mice.
Multipotent NSCs are defined as cells that can self-renew and
differentiate into the three neuronal lineages, neuron, astrocyte,
and oligodendrocyte (Gage, 2000). In the SC, NSCs known as
ependymal cells in the central canal proliferate rapidly after
SCI and differentiate into more than half the astrocytes in the
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FIGURE 5 | Astrocytic scar formation and
neuroinflammation-associated cells at 2 weeks post-injury. (A,E)
Representative images of sagittal sections showing GFAP+ reactive astrocytes
and Iba1+ cells at 2 weeks post-injury. (B,C,F,G) Higher magnification images
from the boxed area, b, c, f and g in (A) and (E). Iba1+ cells were compacted
to the lesion center between rostrocaudal reactive astrocytes, which was
more apparent in the SC of p38α+/− mice than that of WT mice. (D,H) Higher
magnification images of GFAP+ reactive astrocytes from the boxed area, d (in
A) and h (in E). GFAP+ reactive astrocytes at 1 mm caudal to the lesion
epicenter decreased in p38α+/− mice compared with WT mice.
glial scar and a small amount of oligodendrocytes (Barnabé-
Heider et al., 2010). Likewise, in vitro, NSCs derived from
adult WT mice easily and exclusively differentiate into astrocyte
with repeating cell passages without appropriate neurotrophic
factors (Seaberg and van der Kooy, 2002; Bull and Bartlett,
2005). Hence, the low differentiation capacity of adult NSC
for neural and oligodendrocytic lineages can limit the recovery
from SCI. We previously reported that NSCs in the adult
hippocampus of p38α+/− mice have much higher self-renewal
activity and neural differentiation capacity compared with those
of WT mice (Yoshioka et al., 2015). These findings tempted
us to think that activity of progenitor cells for oligodendrocyte
and neuron might be upregulated in p38α+/− mice under the
tissue regeneration process after SCI. To elucidate this point,
we observed cell populations of oligodendrocyte precursor cells
(OPCs) and neural progenitor cells in the lesion epicenter of
SC at 2 wpi. As we expected, the number of NG2+ OPCs in
the white matter of the lesion increased in the two genotypes
at 2 wpi, which was significantly higher in p38α+/− mice
than in WT mice (Figure 6). NG2+ OPCs into the injured
SC can enhance remyelination of spared axons and improve
functional recovery after SCI (Whittaker et al., 2012). Thus,
in conjunction with the results shown in Figures 2B,C, the
increase in OPCs in p38α+/− mice after SCI may contribute
to the efficiency of remyelination under the tissue regeneration
process. We also determined that NG2+ cells were more
accumulated along the laceration/epicenter in p38α+/− mice
compared with WT mice (data not shown). This accumulation
was very similar to typical histopathological findings in CNS
damages including SCI (Tan et al., 2005). NG2 is a member of
chondroitin sulphate proteoglycans (CSPGs) generally known
to be repulsive to growing axons. However, NG2 also called
CSPG4 has been recently recognized as a promoting molecule
for axonal growth and regeneration (Yang et al., 2006). In fact,
it has been demonstrated that astrocytes forming a bridge across
a scar after SCI highly express CSPG4/NG2 (Anderson et al.,
2016). Likewise, NG2+ OPCs provide an adhesive substrate
for axonal growth by forming a bridge after SCI (Busch
et al., 2010). Although we could not detected the astrocytic
bridge between rostrocaudal glial scars in the two genotypes
(Figure 5), the fact that accumulation of NG2+ OPCs along
the laceration/epicenter was more apparent in p38α+/− mice
compared with WT mice might affect the efficiency of axonal
regeneration between the two genotypes. In addition to the
upregulation of OPC recruitment in p38α+/− mice, an increase
in DCX+ neural progenitor cells in the gray matter of the
lesion was bigger in p38α+/− mice than in WT mice at 2 wpi.
Some of the DCX+ neural progenitor cells also expressed
Nestin and were observed in area proximal to the lesion
epicenter in the two genotypes. Notably, DCX+Nestin+ cells
were also detected within the epicenter in case of p38α+/−
mice but not WT mice (Supplementary Figure 2). DCX+Nestin+
cells have been identified as resident multipotent NSCs in
the SC meninges and at least contribute to parenchymal
reaction following SCI (Decimo et al., 2011). Although it is
still unclear whether the DCX+Nestin+ cells recruited into
the lesion contribute to neural regeneration, the finding that
recruitment of neuroblasts and resident NSCs to the lesion
was upregulated in p38α+/− mice may affect the subsequent
tissue regeneration in concert with the enhanced recruitment of
OPCs.
Together, a single copy disruption of p38α gene affected the
tissue degeneration and regeneration processes and improved
the functional recovery from SCI. However, the question arose
as to whether the SCI-augmented p38 activation was inhibited
in the SC of p38α+/− mice. Although SCI did not affect each
expression level of p38α in the two genotypes, the SCI-augmented
p38 activation was less in p38α+/− mice compared with WT
mice (Supplementary Figure 3). Therefore, we finally evaluated
the effect of a p38 inhibitor on the functional recovery from SCI.
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FIGURE 6 | Change in numbers of NG2+ cells in the white matter at
2 weeks after SCI. (A) Typical profile of NG2+ cells in the lesion epicenter of
the two genotypes at 2 weeks post-injury. (B) NG2+ cells in the injured site
within 500 µm rostrocaudal of the lesion epicenter in the SCI group were
increased in the two genotypes at 1 week post-injury, the number of which
was significantly higher in p38α+/− mice (closed bars) than WT mice (open
bars). Data are shown as mean ± SEM (n = 4–5). ∗P < 0.05 (ANOVA followed
by Tukey’s test).
A p38 Inhibitor Improved Locomotor
Recovery after SCI
Unlike the previous studies on the association between SCI and
a p38 inhibitor (Horiuchi et al., 2003; Stirling et al., 2008), we
used SB239063 as a p38 inhibitor that is an orally active and
transferable across the blood-cerebrospinal fluid barrier. In the
preliminary study, we confirmed that an oral administration
of SB239063 (10 mg/kg body weight) could efficiently inhibit
the SCI-induced p38α activity (Supplementary Figure 4). Then,
based on a previous report that the strong activation of p38
MAPK in the injured SC increases from 12 h to 3 days (Song et al.,
2013), we orally administrated SB239063 to WT mice (10 mg/kg
per day) at 1, 2, and 3 dpi. As we expected, the BMS score
was significantly higher in the SB239063-treated group compared
with the vehicle group over a time period ranging from 6 to 28 dpi
(Figure 7), indicating that a pharmacological inhibition of p38α
also improved the recovery of hindlimb behavior after SCI.
Our present result that SB239063 is effective on the functional
recovery after lateral hemisection of the SC can be supported by
the previous study employing a mild contusion model of SCI
by Horiuchi et al. (2003). On the other hand, another study
FIGURE 7 | Effect of SB239063 on hindlimb locomotor behavior after
SCI. WT mice with SCI received oral administration of vehicles (filled squares)
and SB239063 (10 mg/kg per day, filled circles) at 1, 2, and 3 dpi. Functional
recovery from SCI was better in mice with SB239063 treatment than those
with vehicle administration. Data are shown as mean ± SEM (n = 6).
∗P < 0.05, a significant difference between the two groups by Mann–Whitney
U test for unpaired values at each time point.
demonstrated that a p38α inhibitor failed to improve functional
outcome after SCI with moderate contusion (Stirling et al., 2008).
Currently, the discrepancy in efficacy of a p38α inhibitor for SCI
between them is difficult to explain. Regardless of the type of
SCI model, however, the intensity of SC damage may influence
the beneficial effect of a p38α inhibitor. In addition, the route
and schedule of administration with a p38α inhibitor also affect
its efficacy. As a next step, to investigate whether our protocol
of SB239063 administration is effective in a moderate contusion
model of SCI is needed.
CONCLUSION
A single copy disruption of p38α gene inhibited the tissue
degenerative events such as leukocytic infiltration, expression
of cytokines/chemokines and apoptosis of oligodendrocyte and
neuron and enhanced the tissue regenerative events such as
compaction of microglias/macrophages, recruitment of OPCs
and NSC and axonal regrowth and remyelination, which resulted
in a better functional recovery from SCI. We also demonstrated
that a pharmacological inhibition of p38α could recapitulate
the better functional recovery from SCI observed in p38α+/−
mice. Our present study clearly suggests that p38α contributes
to the pathogenesis of SCI and propose that an orally active
p38α inhibitor, SB239063 may have therapeutic benefits for the
treatment of SCI.
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